We recently found that estrogen can increase DNMT1 expression, thereby increasing DNA methylation in the promoter of p53 and thus inhibiting p53 expression, leading to the repolarization of tumor-associated macrophages from the M1 to the M2 phenotype, which promotes cancer progression [26]. The gene discussed is TP53; the disease is cancer.